What Innovators Can Expect In The Patent World After Amgen
The U.S. Supreme Court handed down a long-awaited decision last month on the enablement standard for a patent under Title 35 of the U.S. Code, Section 112(a) in Amgen Inc. v....To view the full article, register now.
Already a subscriber? Click here to view full article